Advertisement

Cryoablation of renal cell carcinoma for patients with stage 4 or 5 non-dialysis chronic kidney disease

  • Hideo GobaraEmail author
  • Atsuhiro Nakatsuka
  • Kanichiro Shimizu
  • Takashi Yamanaka
  • Yusuke Matsui
  • Toshihiro Iguchi
  • Takao Hiraki
  • Koichiro Yamakado
Original Article
  • 32 Downloads

Abstract

Purpose

To evaluate the safety and efficacy of cryoablation for renal cell carcinoma (RCC) in patients with stage 4 or 5 non-dialysis chronic kidney disease (CKD).

Materials and methods

This retrospective multicenter study included patients with maximum tumor diameter ≤ 4 cm, estimated glomerular filtration rate (eGFR) < 30 ml/min/1.73 m2, in whom cryoablation was performed percutaneously with curative intent between July 2011 and May 2016.

Results

Of 541 patients who underwent renal tumor cryoablation, 17 (3.1%; 4 women, 13 men; mean age 70.1 ± 10.6 years) with stage 4 or 5 non-dialysis CKD were included in this study. The pre-cryoablation eGFR was 22.5 ± 6.3 ml/min/1.73 m2. The mean tumor diameter was 2.8 ± 0.7 cm. No Grade 3 or higher adverse events occurred post-cryoablation. The eGFR at each time point was significantly lower than that before treatment. One patient required hemodialysis initiation at 21 months post-procedure. None of the patients showed residual RCC at their last follow-up.

Conclusion

Cryoablation of RCC is safe in patients with stage 4 or 5 non-dialysis CKD and yields treatment results comparable to those in patients without CKD. This treatment could be completed without the early initiation of hemodialysis after the procedure.

Keywords

Chronic kidney disease Cryoablation Renal cell carcinoma Kidney Stage 4 

Notes

Funding

Nothing to disclose.

Compliance with ethical standards

Conflict of interest

Hideo Gobara and Takao Hiraki received funding from Okayama Prefecture, JPSS and AMED. Other authors have no conflict of interest to declare.

Ethical statement

Each institutional review board approved this retrospective multicenter study and waived the requirement for obtaining informed consent to use the patients’ medical data. All procedures performed were in accordance with the ethical standards of the institutional research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

  1. 1.
    Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015;67:519–30.CrossRefGoogle Scholar
  2. 2.
    Patard JJ. Incidental renal tumours. Curr Opin Urol. 2009;19:454–8.CrossRefGoogle Scholar
  3. 3.
    Rabjerg M, Mikkelsen MN, Walter S, Marcussen N. Incidental renal neoplasms: is there a need for routine screening? A Danish single-center epidemiological study. APMIS. 2014;122:708–14.CrossRefGoogle Scholar
  4. 4.
    Schmit GD, Thompson RH, Kurup AN, Weisbrod AJ, Carter RE, Callstrom MR, et al. Percutaneous cryoablation of solitary sporadic renal cell carcinomas. BJU Int. 2012;110(11 Pt B):E526–31.CrossRefGoogle Scholar
  5. 5.
    Georgiades CS, Rodriguez R. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study. Cardiovasc Interv Radiol. 2014;37:1494–9.CrossRefGoogle Scholar
  6. 6.
    Aoun HD, Littrup PJ, Jaber M, Memon F, Adam B, Krycia M, et al. Percutaneous cryoablation of renal tumors: is it time for a new paradigm shift? J Vasc Interv Radiol. 2017;28:1363–70.CrossRefGoogle Scholar
  7. 7.
    Patel HD, Pierorazio PM, Johnson MH, Sharma R, Iyoha E, Allaf ME, et al. Renal functional outcomes after surgery, ablation, and active surveillance of localized renal tumors: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2017;12:1057–69.CrossRefGoogle Scholar
  8. 8.
    Wehrenberg-Klee E, Clark TW, Malkowicz SB, Soulen MC, Wein AJ, Mondschein JI, et al. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. J Vasc Interv Radiol. 2012;23:41–5.CrossRefGoogle Scholar
  9. 9.
    Miyazaki M, Iguchi T, Takaki H, Yamanaka T, Tamura Y, Tokue H, et al. Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts. Jpn J Radiol. 2016;34:647–56.CrossRefGoogle Scholar
  10. 10.
    Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.CrossRefGoogle Scholar
  11. 11.
    Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182:844–53.CrossRefGoogle Scholar
  12. 12.
    Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034–47.CrossRefGoogle Scholar
  13. 13.
    Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305. (Erratum in: N Engl J Med 2008;18:4).CrossRefGoogle Scholar
  14. 14.
    Levin A, Djurdjev O, Beaulieu M, Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis. 2008;52:661–71.CrossRefGoogle Scholar
  15. 15.
    O'Hare AM, Bertenthal D, Walter LC, Garg AX, Covinsky K, Kaufman JS, et al. When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration? Kidney Int. 2007;71:555–61.CrossRefGoogle Scholar
  16. 16.
    Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67:913–24.CrossRefGoogle Scholar
  17. 17.
    Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, et al. Kidney cancer, version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2017;15:804–34.CrossRefGoogle Scholar
  18. 18.
    Mason RJ, Atwell TD, Lohse C, Bhindi B, Weisbrod A, Boorjian SA, et al. Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass. BJU Int. 2017;120:544–9.CrossRefGoogle Scholar
  19. 19.
    Maurice MJ, Ramirez D, Kara Ö, Malkoç E, Nelson RJ, Fareed K, et al. Optimum outcome achievement in partial nephrectomy for T1 renal masses: a contemporary analysis of open and robot-assisted cases. BJU Int. 2017;120:537–43.CrossRefGoogle Scholar
  20. 20.
    Long JA, Bernhard JC, Bigot P, Lanchon C, Paparel P, Rioux-Leclercq N, et al. Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting. World J Urol. 2017;35:649–56.CrossRefGoogle Scholar
  21. 21.
    Georgiades C, Rodriguez R, Azene E, Weiss C, Chaux A, Gonzalez-Roibon N, et al. Determination of the nonlethal margin inside the visible "ice-ball" during percutaneous cryoablation of renal tissue. Cardiovasc Interv Radiol. 2013;36:783–90.CrossRefGoogle Scholar
  22. 22.
    Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003;349:1333–400.CrossRefGoogle Scholar
  23. 23.
    Thomsen HS. Nephrogenic systemic fibrosis: history and epidemiology. Radiol Clin N Am. 2009;47:827–81.CrossRefGoogle Scholar
  24. 24.
    Ellison JS, Montgomery JS, Hafez KS, Miller DC, He C, Wolf JS Jr, et al. Association of RENAL nephrometry score with outcomes of minimally invasive partial nephrectomy. Int J Urol. 2013;20:564–70.CrossRefGoogle Scholar
  25. 25.
    Roushias S, Vasdev N, Ganai B, Mafeld S, Rix D, Thomas D, et al. Can the R.e.N.a.L nephrometry score preoperatively predict postoperative clinical outcomes in patients undergoing open and laparoscopic partial nephrectomy? Curr Urol. 2013;7:90–7.CrossRefGoogle Scholar
  26. 26.
    Sisul DM, Liss MA, Palazzi KL, Briles K, Mehrazin R, Gold RE, et al. RENAL nephrometry score is associated with complications after renal cryoablation: a multicenter analysis. Urology. 2013;81:775–80.CrossRefGoogle Scholar
  27. 27.
    Blute Jr ML, Okhunov Z, Moreira DM, George AK, Sunday S, Lobko II K, et al. Image-guided percutaneous renal cryoablation: preoperative risk factors for recurrence and complications. BJU Int. 2013;111(4 Pt B):E181–85.CrossRefGoogle Scholar

Copyright information

© Japan Radiological Society 2019

Authors and Affiliations

  1. 1.Department of RadiologyOkayama University Medical SchoolOkayamaJapan
  2. 2.Department of Interventional RadiologyMie University HospitalTsuJapan
  3. 3.Department of RadiologyThe Jikei University School of Medicine, Kashiwa HospitalKashiwaJapan
  4. 4.Department of RadiologyThe Hospital of Hyogo College of MedicineNishinomiyaJapan

Personalised recommendations